Harvard, 10x Gene-Mapping Patent Cases Prompt Vizgen ‘Bombshell’
Courtroom attacks that 10x Genomics Inc. and Harvard College launched over gene-mapping technology patents have exposed the collaborators to “bombshell revelations”—uncovered by one of the defendants—that Harvard and 10x broke “long-hidden” promises to openly license “the fruits of government-funded biotechnology research.”